Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed combination of disodium cromoglycate plus reproterol versus single components and placebo in adults with exercise-induced asthma
2007-002553-23Phase 2Completed
- Sponsor
- Meda
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of disodium cromoglycate + reproterol in exercise-induced bronchospasm (EIB) (4 arms), sponsored by Meda. Primary endpoints: Maximum percentage decrease in FEV1 from baseline (fixed combination vs reproterol) and Maximum percentage decrease in FEV1 from baseline (other comparisons). Started Jul 2007; status: completed.
02
Drugs
disodium cromoglycate + reproterol
03
Conditions
exercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on 2007-002553-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002553-23.